Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David McCarey

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Rheumatology Reports|January 8, 2008
Psoriatic arthritis: current topicsDavid McCarey, Iain B McInnes
The Journal of Rheumatology|October 11, 2002
"5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapyHilary Capell, David McCarey, Rajan Madhok, et al.
Annals of the Rheumatic Diseases|September 17, 2017
Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritisJamie Robertson, Duncan Porter, Naveed Sattar, et al.
Rheumatology (Oxford, England)|August 31, 2015
Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammationPamela B Wright, Anne McEntegart, David McCarey, et al.
Nature Communications|June 23, 2017
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritisMariola Kurowska-Stolarska, Stefano Alivernini, Emma Garcia Melchor, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Rheumatology Reports|January 8, 2008
Psoriatic arthritis: current topicsDavid McCarey, Iain B McInnes
The Journal of Rheumatology|October 11, 2002
"5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapyHilary Capell, David McCarey, Rajan Madhok, et al.
Annals of the Rheumatic Diseases|September 17, 2017
Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritisJamie Robertson, Duncan Porter, Naveed Sattar, et al.
Rheumatology (Oxford, England)|August 31, 2015
Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammationPamela B Wright, Anne McEntegart, David McCarey, et al.
Nature Communications|June 23, 2017
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritisMariola Kurowska-Stolarska, Stefano Alivernini, Emma Garcia Melchor, et al.
Pageof 1